Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are overprescribing them and some patients are taking them in secret.

On July 18, 2025, Director Jeffrey S. Flier disclosed the sale of 11,136 shares of Scholar Rock( SRRK -0.68%) in an open ...

The drugmaker plans to launch Semaglutide in 87 countries next year, including those where patents are expiring and emerging ...

People are buying weight loss drugs online but the cut-price deals may not be what they seem to be, health chiefs warned. The NHS has recently started prescribing the miracle cures – commonly known as ...

Initially, Dr Reddy's will focus on launching the generic semaglutide in Canada, India, Brazil, Turkey, and other emerging ...

Welcome to our live blog tracking the latest news and developments from Canada. Stay updated with real-time insights into the ...

Q1 may have held steady, but the second half of FY26 will test Dr Reddy’s transition strategy. Without Revlimid, and with US pressure persisting, the Street will now watch execution timelines — not ...

Researchers at the University of Manitoba are looking at how marketing for drugs like Ozempic and Wegovy influence peoples' ...

The "try and fail" language is flawed when weight loss is used as the primary measure of success with lifestyle interventions ...

Gut health is finally becoming cool, which means more brands are touting the fiber available in their products.

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...